In myocardial perfusion SPET studies with 99Tcm-Q12, we observed that some patients had high liver uptake that interfered significantly in the assessment of the inferior wall. The aim of this study was to assess the effects of the radiochemical purity of 99Tcm-Q12 on liver uptake. Thirty- one patients undergoing routine myocardial infarction perfusion studies were evaluated. The radiochemical purity of 99Tcm Q12 was determined using HPLC. Venous blood samples taken 50 min after injection of 99Tcm-Q12 during peak exercise were also analysed. Liver uptake was expressed as the liver-to-heart ratio. In addition, the SPET images were classified by two experienced nuclear medicine specialists into three groups representing high- quality images (n = 7), images with high general background activity (n = 13) and images with high liver and/or intestinal uptake (n = 11). The liver-to- heart ratio correlated inversely with the radiochemical purity of 99Tcm - Q12 (r= -0.65, P < 0.001) and unchanged 99Tcm -Q12 in plasma (r = -0.44, P < 0.02). The radiochemical purity of 99Tcm-Q12 was significantly lower in the group with high liver uptake (60.1 ± 4.2%) than in the group with good- quality images (81.8 ± 5.6%, P < 0.01) or with high background activity (82.3 ± 2.5%, P < 0.01). In conclusion, the radiochemical purity of 99Tcm-Q12 has a significant inverse correlation with the liver-to-heart ratio; thus, the high radiochemical purity of 99Tcm-Q12 should be confirmed to prevent interference by liver uptake.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging